{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:36:46Z","timestamp":1763696206755,"version":"3.45.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.7759\/cureus.97373","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T01:56:27Z","timestamp":1763690187000},"source":"Crossref","is-referenced-by-count":0,"title":["When 25% Feels Like 100%: Confronting Recurrent Cystic Fibrosis Risk Across Consecutive Pregnancies"],"prefix":"10.7759","author":[{"given":"Sujoy","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipanjana","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumyajit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusagradhi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamal","family":"Sett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg M","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021, 397:2195-211. 10.1016\/S0140-6736(20)32542-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ame2.12180","article-title":"A review of cystic fibrosis: basic and clinical aspects","volume":"4","author":"Chen Q","year":"2021","unstructured":"Chen Q, Shen Y, Zheng J. A review of cystic fibrosis: basic and clinical aspects. Animal Model Exp Med. 2021, 4:220-32. 10.1002\/ame2.12180","journal-title":"Animal Model Exp Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2020.04.05","article-title":"Genetics of CFTR and male infertility","volume":"10","author":"Bieniek JM","year":"2021","unstructured":"Bieniek JM, Lapin CD, Jarvi KA. Genetics of CFTR and male infertility. Transl Androl Urol. 2021, 10:1391-400. 10.21037\/tau.2020.04.05","journal-title":"Transl Androl Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/17534666251340334","article-title":"Perspectives of people with cystic fibrosis considering parenthood surrounding preconception and prenatal genetic counseling and testing","volume":"19","author":"Rajanikanth G","year":"2025","unstructured":"Rajanikanth G, Prangley A, Stransky OM, Langfelder-Schwind E, Vento J, Felter E, Kazmerski TM. Perspectives of people with cystic fibrosis considering parenthood surrounding preconception and prenatal genetic counseling and testing. Ther Adv Respir Dis. 2025, 19:17534666251340334. 10.1177\/17534666251340334","journal-title":"Ther Adv Respir Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0215-5","article-title":"Genomics of rare genetic diseases-experiences from India","volume":"14","author":"Sivasubbu S","year":"2019","unstructured":"Sivasubbu S, Scaria V. Genomics of rare genetic diseases-experiences from India. Hum Genomics. 2019, 14:52. 10.1186\/s40246-019-0215-5","journal-title":"Hum Genomics"},{"key":"ref6","article-title":"Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis","volume":"40","author":"Kabra SK","year":"2003","unstructured":"Kabra SK, Kabra M, Lodha R, et al.. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr. 2003, 40:612-9.","journal-title":"Indian Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2005.10.002","article-title":"Carrier frequency of F508del mutation of cystic fibrosis in Indian population","volume":"5","author":"Kapoor V","year":"2006","unstructured":"Kapoor V, Shastri SS, Kabra M, et al.. Carrier frequency of F508del mutation of cystic fibrosis in Indian population. J Cyst Fibros. 2006, 5:43-6. 10.1016\/j.jcf.2005.10.002","journal-title":"J Cyst Fibros"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20677","article-title":"Cystic fibrosis in India","volume":"42","author":"Kabra SK","year":"2007","unstructured":"Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007, 42:1087-94. 10.1002\/ppul.20677","journal-title":"Pediatr Pulmonol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-010-0091-1","article-title":"Molecular basis of cystic fibrosis disease: an Indian perspective","volume":"25","author":"Prasad R","year":"2010","unstructured":"Prasad R, Sharma H, Kaur G. Molecular basis of cystic fibrosis disease: an Indian perspective. Indian J Clin Biochem. 2010, 25:335-41. 10.1007\/s12291-010-0091-1","journal-title":"Indian J Clin Biochem"},{"key":"ref10","article-title":"Cystic fibrosis in India: a systematic review","volume":"60","author":"Ashavaid TF","year":"2012","unstructured":"Ashavaid TF, Raghavan R, Dhairyawan P, Bhawalkar S. Cystic fibrosis in India: a systematic review. J Assoc Physicians India. 2012, 60:39-41.","journal-title":"J Assoc Physicians India"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.06.008","article-title":"Function, pharmacological correction and maturation of new Indian CFTR gene mutations","volume":"14","author":"Sharma H","year":"2015","unstructured":"Sharma H, Jollivet Souchet M, Callebaut I, Prasad R, Becq F. Function, pharmacological correction and maturation of new Indian CFTR gene mutations. J Cyst Fibros. 2015, 14:34-41. 10.1016\/j.jcf.2014.06.008","journal-title":"J Cyst Fibros"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-014-0369-0","article-title":"CFTR mutations in India: need to do more!: geneticist's perspective","volume":"51","author":"Girisha KM","year":"2014","unstructured":"Girisha KM. CFTR mutations in India: need to do more!: geneticist's perspective. Indian Pediatr. 2014, 51:177-8. 10.1007\/s13312-014-0369-0","journal-title":"Indian Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.24966\/PMRR-0177\/100002","article-title":"Cystic fibrosis in India: past, present and future","volume":"1","author":"Mandal A","year":"2015","unstructured":"Mandal A, Kabra SK, Lodha R. Cystic fibrosis in India: past, present and future. J Pulm Med Respir Res. 2015, 1:002. 10.24966\/PMRR-0177\/100002","journal-title":"J Pulm Med Respir Res"},{"key":"ref14","article-title":"Molecular and functional basis of cystic fibrosis in Indian patients: genetic, diagnostic and therapeutic implications","volume":"54","author":"Prasad R","year":"2018","unstructured":"Prasad R. Molecular and functional basis of cystic fibrosis in Indian patients: genetic, diagnostic and therapeutic implications. Ann Natl Acad Med Sci. 2018, 54:216-30.","journal-title":"Ann Natl Acad Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2024.100434","article-title":"CFTR mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India","volume":"27","author":"Varkki SD","year":"2024","unstructured":"Varkki SD, Aaron R, Chapla A, Danda S, Medhi P, Jansi Rani N, Paul GR. CFTR mutations and phenotypic correlations in people with cystic fibrosis: a retrospective study from a single centre in south India. Lancet Reg Health Southeast Asia. 2024, 27:100434. 10.1016\/j.lansea.2024.100434","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijns11020027","article-title":"India: The last and best frontier for cystic fibrosis newborn screening with perspectives on special challenges","volume":"11","author":"Farrell PM","year":"2025","unstructured":"Farrell PM, Paul GR, Varkki SD. India: The last and best frontier for cystic fibrosis newborn screening with perspectives on special challenges. Int J Neonatal Screen. 2025, 11:27. 10.3390\/ijns11020027","journal-title":"Int J Neonatal Screen"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001951","article-title":"Committee opinion no. 690: carrier screening in the age of genomic medicine","volume":"129","year":"2017","unstructured":"Committee opinion no. 690. carrier screening in the age of genomic medicine. Obstet Gynecol. 2017, 129:e35-40. 10.1097\/AOG.0000000000001951","journal-title":"Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100867","article-title":"Updated recommendations for CFTR carrier screening: a position statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Deignan JL","year":"2023","unstructured":"Deignan JL, Gregg AR, Grody WW, et al.. Updated recommendations for CFTR carrier screening: a position statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023, 25:100867. 10.1016\/j.gim.2023.100867","journal-title":"Genet Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/432955-when-25-feels-like-100-confronting-recurrent-cystic-fibrosis-risk-across-consecutive-pregnancies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T01:56:28Z","timestamp":1763690188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/432955-when-25-feels-like-100-confronting-recurrent-cystic-fibrosis-risk-across-consecutive-pregnancies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.97373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}